“Our operational activities and workflows are designed to support and ensure ISO International Standards implementation across the whole group.”
BMS–UK Co-existing with Mozaic Dx it supports Platform development of our IT systems & developing Diagnostic product line (JUNO™, IOS™ and QRS™). It also accommodates a Manufacturing component to supplement ISO13485 material development and packaging. The premises are split to support the trinity of activities: high end diagnostics, R&D and manufacturing of our propriety products. Our central offices are also located in this facility encompassing 180m2. BMS-Egypt is located in Cairo, Egypt. It currently operational as a service facility for client logistics, integrating the groups portfolio in support of the local market and also several B2B operations. It is located in central Cairo with access through partnerships to all major cities and towns in Egypt. As a facility it consist of 60m2 of welcome, laboratory & office space. BioPath Innovations – Athens, operates as a Core Molecular Pathology Unit offering an extensive portfolio of Diagnostic procedures primarily hemato-oncology and pathology. Together with BMS – UK it is involved in validation of materials, diagnostics and IT based systems and reagents within the BMS pipeline. It offers routine Diagnostic services to the local market and BMS Group operations. It consists of 120m2 laboratory & office space.Cairo, Egypt
33 Al Moltaka Al Araby Sheraton
Heliopolis, Cairo
Mob: 00201097211823
egypt@biomarkersolutions.com
Copyright © Biomarker Solutions LTD
20-21 Wolsey Mews, London, NW5 2DX Registered in England and Wales / Companies House Registration Number: 08249204